MELANOMA, CUTANEOUS MALIGNANT

Clinical trials for MELANOMA, CUTANEOUS MALIGNANT explained in plain language.

Never miss a new study

Get alerted when new MELANOMA, CUTANEOUS MALIGNANT trials appear

Sign up with your email to follow new studies for MELANOMA, CUTANEOUS MALIGNANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Personalized immune cells battle advanced skin cancer in major trial

Disease control Recruiting now

This trial is testing whether a personalized cell therapy called IMA203 works better than standard treatments for advanced melanoma that has spread and hasn't responded to previous therapies. The treatment uses the patient's own immune cells that are specially engineered to attac…

Matched conditions: MELANOMA, CUTANEOUS MALIGNANT

Phase: PHASE3 • Sponsor: Immatics US, Inc. • Aim: Disease control

Last updated Mar 17, 2026 13:09 UTC

MELANOMA, CUTANEOUS MALIGNANT

Get alerted when new MELANOMA, CUTANEOUS MALIGNANT trials appear

Personalized immune cells battle advanced skin cancer in major trial